Biotech API Manufacturing Services Market

Biotech API Manufacturing Services Market (Service Type: API Process Development & Manufacturing, Analytical Testing & Quality Control, Regulatory Support, and Scale-up & Commercial Manufacturing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Biotech API Manufacturing Services Market – Scope of Report

TMR’s report on the global biotech API manufacturing services market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global biotech API manufacturing services market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global biotech API manufacturing services market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the biotech API manufacturing services market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global biotech API manufacturing services market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global biotech API manufacturing services market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global biotech API manufacturing services market.

The report delves into the competitive landscape of the global biotech API manufacturing services market. Key players operating in the global biotech API manufacturing services market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global biotech API manufacturing services market profiled in this report.

Key Questions Answered in Global Biotech API Manufacturing Services Market Report
  • What is the sales/revenue generated by biotech API manufacturing services across all regions during the forecast period?
  • What are the opportunities in the global biotech API manufacturing services market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Biotech API Manufacturing Services Market – Research Objectives and Research Approach

The comprehensive report on the global biotech API manufacturing services market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global biotech API manufacturing services market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global biotech API manufacturing services market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biotech API Manufacturing Services Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biotech API Manufacturing Services Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Overview of API Manufacturing Services in Biotechnology Industry
5.2. Regulatory Scenario, by Region
5.3. Value Chain Analysis
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long term impact)
6. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Service Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Service Type, 2017-2031
6.3.1. API Process Development & Manufacturing
6.3.2. Analytical Testing & Quality Control
6.3.3. Regulatory Support
6.3.4. Scale-up & Commercial Manufacturing
6.4. Market Attractiveness Analysis, by Service Type
7. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Scale of Operations
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Scale of Operations, 2017-2031
7.3.1. Small-scale
7.3.2. Mid-scale
7.3.3. Large-scale
7.4. Market Attractiveness Analysis, by Scale of Operations
8. Global Biotech API Manufacturing Services Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Biotech API Manufacturing Services Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Service Type, 2017-2031
9.2.1. API Process Development & Manufacturing
9.2.2. Analytical Testing & Quality Control
9.2.3. Regulatory Support
9.2.4. Scale-up & Commercial Manufacturing
9.3. Market Value Forecast, by Scale of Operations, 2017-2031
9.3.1. Small-scale
9.3.2. Mid-scale
9.3.3. Large-scale
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Service Type
9.5.2. By Scale of Operations
9.5.3. By Country
10. Europe Biotech API Manufacturing Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Service Type, 2017-2031
10.2.1. API Process Development & Manufacturing
10.2.2. Analytical Testing & Quality Control
10.2.3. Regulatory Support
10.2.4. Scale-up & Commercial Manufacturing
10.3. Market Value Forecast, by Scale of Operations, 2017-2031
10.3.1. Small-scale
10.3.2. Mid-scale
10.3.3. Large-scale
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Service Type
10.5.2. By Scale of Operations
10.5.3. By Country/Sub-region
11. Asia Pacific Biotech API Manufacturing Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Service Type, 2017-2031
11.2.1. API Process Development & Manufacturing
11.2.2. Analytical Testing & Quality Control
11.2.3. Regulatory Support
11.2.4. Scale-up & Commercial Manufacturing
11.3. Market Value Forecast, by Scale of Operations, 2017-2031
11.3.1. Small-scale
11.3.2. Mid-scale
11.3.3. Large-scale
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. India
11.4.3. Japan
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Service Type
11.5.2. By Scale of Operations
11.5.3. By Country/Sub-region
12. Latin America Biotech API Manufacturing Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Service Type, 2017-2031
12.2.1. API Process Development & Manufacturing
12.2.2. Analytical Testing & Quality Control
12.2.3. Regulatory Support
12.2.4. Scale-up & Commercial Manufacturing
12.3. Market Value Forecast, by Scale of Operations, 2017-2031
12.3.1. Small-scale
12.3.2. Mid-scale
12.3.3. Large-scale
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Service Type
12.5.2. By Scale of Operations
12.5.3. By Country/Sub-region
13. Middle East & Africa Biotech API Manufacturing Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Service Type, 2017-2031
13.2.1. API Process Development & Manufacturing
13.2.2. Analytical Testing & Quality Control
13.2.3. Regulatory Support
13.2.4. Scale-up & Commercial Manufacturing
13.3. Market Value Forecast, by Scale of Operations, 2017-2031
13.3.1. Small-scale
13.3.2. Mid-scale
13.3.3. Large-scale
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Service Type
13.5.2. By Scale of Operations
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2022
14.3. Company Profiles
14.3.1. Lonza Group Ltd.
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. WuXi AppTec Co., Ltd.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Boehringer Ingelheim Biopharmaceuticals GmbH (Boehringer Ingelheim International GmbH)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. CordenPharma International
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Sterling Pharma Solutions
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. AbbVie, Inc.
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Hikal Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Almac Group
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. FUJIFILM Diosynth Biotechnologies
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. Abzena Ltd
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. Regis Technologies, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Rentschler Biopharma SE
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. Catalent, Inc.
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Product Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings